» Authors » Benjamin Walbaum

Benjamin Walbaum

Explore the profile of Benjamin Walbaum including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 77
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramirez-Parada K, Sanchez C, Cantarero-Villanueva I, Reyes A, Pinto M, Loreto Bravo M, et al.
Arch Phys Med Rehabil . 2025 Mar; PMID: 40081785
Objective: to evaluate if combining prospective surveillance model (PSM) with a supervised multimodal exercise program prevents breast cancer-related lymphedema (BCRL) and its impact on the functional capacity and quality of...
2.
Torres A, Quintanilla F, Barnafi E, Sanchez C, Acevedo F, Walbaum B, et al.
Nutrients . 2024 Sep; 16(17). PMID: 39275213
Cancer, the second leading cause of death worldwide, demands the identification of modifiable risk factors to optimize its prevention. Diet has emerged as a pivotal focus in current research efforts....
3.
Walbaum B, Garcia-Fructuoso I, Martinez-Saez O, Schettini F, Sanchez C, Acevedo F, et al.
Cancer Treat Rev . 2024 Jul; 129:102804. PMID: 39084152
The incidence of breast cancer in ≤ 40 yr-old women (YWBC) has been steadily increasing in recent decades. Although this group of patients represents less than 10 % of all...
4.
Marin A, Morales F, Walbaum B
Front Oncol . 2024 Jul; 14:1406951. PMID: 39040443
Fibroblast Growth Factor Receptors (FGFRs) play a significant role in Estrogen Receptor-positive (ER+) breast cancer by contributing to tumorigenesis and endocrine resistance. This review explores the structure, signaling pathways, and...
5.
Valenzuela R, Walbaum B, Farias C, Acevedo F, Vargas C, Bennett J, et al.
Nutrition . 2024 Mar; 121:112357. PMID: 38430738
Objective: Polyunsaturated fatty acids are categorized as ω-3 or ⍵-6. Previous studies demonstrate that breast cancers display a high expression of fatty acid synthase and high fatty acid levels. Our...
6.
Walbaum B, Reyes J, Rodriguez P, Muniz S, Medina L, Ibanez C, et al.
Ecancermedicalscience . 2024 Feb; 17:1636. PMID: 38414945
Background: The addition of cyclin-dependent kinases inhibitors (CDKi) to endocrine therapy (ET) as the first- or second line treatment improves progression-free and overall survival (OS) in hormone receptor-positive, HER2 negative...
7.
Vega C, Barnafi E, Sanchez C, Acevedo F, Walbaum B, Parada A, et al.
Nutrients . 2024 Feb; 16(4). PMID: 38398802
This study assesses the feasibility of calorie restriction (CR) and time-restricted feeding (TRF) in overweight and obese cancer patients who realized little to no physical activity undergoing curative radiotherapy, structured...
8.
Ramirez-Parada K, Gonzalez-Santos A, Riady-Aleuy L, Pinto M, Ibanez C, Merino T, et al.
Curr Oncol . 2023 Sep; 30(9):8068-8077. PMID: 37754500
Breast cancer-related lymphedema (BCRL) is characterized by arm swelling, pain, and discomfort, reducing the quality of life (QoL) of affected individuals. BRCL is caused via the blockage or disruption of...
9.
Heredia A, Walbaum B, Vidal M, Itriago L, Camus M, Dominguez F, et al.
Breast Cancer Res Treat . 2023 Sep; 203(1):173-179. PMID: 37733187
Purpose: The incidence of breast cancer in young women (BCYW) has increased in recent decades. Malignant disease in this subset is characterized by its aggressiveness and poor prognosis. Ovarian function...
10.
Mondaca S, Walbaum B, Le Corre N, Ferres M, Valdes A, Martinez-Valdebenito C, et al.
Vaccines (Basel) . 2023 Jul; 11(7). PMID: 37515009
Cancer patients on chemotherapy have a lower immune response to SARS-CoV-2 vaccines. Therefore, through a prospective cohort study of patients with solid tumors receiving chemotherapy, we aimed to determine the...